Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Brain Tumor Pathology|November 7, 2008
Chordoid meningioma arising in the pineal region: a case reportShintaro Fukushima, Mizuhiko Terasaki, Minoru ShigemoriCurrent Opinion in Psychology|August 26, 2019
How do socio-ecological factors shape culture? Understanding the process of micro-macro interactionsYukiko Uchida, Kosuke Takemura, Shintaro FukushimaInternational Journal of Psychology : Journal International De Psychologie|February 2, 2021
Do you feel happy when other members look happy? Moderating effect of community-level social capital on interconnection of happinessShintaro Fukushima, Yukiko Uchida, Kosuke TakemuraCurrent Opinion in Psychology|December 14, 2023
Interdependent culture and older adults' well-being: Health and psychological happiness in Japanese communitiesYukiko Uchida, Mariko Kanamori, Shintaro Fukushima, et al.International Journal of Oncology|November 6, 2007
Cell density-dependent regulation of tumor necrosis factor alpha gene expression in a human hepatoma cell lineShintaro Fukushima, Naoyuki Kaneko, Osamu Koiwai, et al.International Journal of Oncology|January 19, 2008
Caspase-9 pathway activation by inhibiting endogenous fibroblast growth factor signaling in human glioma cellsShintaro Fukushima, Seiya Kato, Mitsuhide Maeda, et al.Neurologia Medico-Chirurgica|September 27, 2013
Lumbosubarachnoid-lumboepidural shunting in patients with idiopathic normal-pressure hydrocephalus: surgical procedures and follow-up study of five casesTotaro Takeuchi, Shintaro Fukushima, Daigoro Misaki, et al.Journal of Neurosurgery|April 5, 2007
Granulocytic sarcoma: an unusual complication of acute promyelocytic leukemia causing cerebellar hemorrhage. Case reportShintaro Fukushima, Mizuhiko Terasaki, Yutaka Tajima, et al.Brain Tumor Pathology|February 15, 2012
Clincopathological analysis of olfactory neuroblastomaShintaro Fukushima, Yasuo Sugita, Daisuke Niino, et al.Surgical Neurology|December 7, 2007
Pilot trial of the rate of response, safety, and tolerability of temozolomide and oral VP-16 in patients with recurrent or treatment-induced malignant central nervous system tumorsMizuhiko Terasaki, Eric Bouffet, Hiroshi Katsuki, et al.Pageof 5